Baptiste Lacoste

Baptiste Lacoste

Auto-generated profile, based on publicly available information

Baptiste Lacoste

University of Ottawa

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2014 in Nature
Verified
Journal Article
Closed access
PDF file
ABAyal Ben-Zvi
Ayal Ben-Zvi
BLBaptiste Lacoste
Baptiste Lacoste
EKEsther Kur
Esther Kur
BABenjamin J. Andreone
Benjamin J. Andreone
YMYoav Mayshar
Yoav Mayshar
CGChenghua Gu
Chenghua Gu

1 May 2017 in Neuron
Verified
Journal Article
Closed access
BABenjamin J. Andreone
Benjamin J. Andreone
BCBrian Wai Chow
Brian Wai Chow
ATAleksandra Tata
Aleksandra Tata
BLBaptiste Lacoste
Baptiste Lacoste
ABAyal Ben-Zvi
Ayal Ben-Zvi
CGChenghua Gu
Chenghua Gu

11 December 2018 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
PDPeter Van Dyken
Peter Van Dyken
BLBaptiste Lacoste
Baptiste Lacoste
Metabolic syndrome, which includes diabetes and obesity, is one of the most widespread medical conditions. It induces systemic inflammation, causing far reaching effects on the body that are still being uncovered. Neuropathologies triggered by metabolic syndrome often result from increased permeability of the blood–brain-barrier (BBB). The BBB, a system designed to restrict entry of toxins, immune cells, and pathogens to the brain, is vital for proper neuronal function. Local and systemic inflammation induced by obesity or type 2 diabetes mellitus can cause BBB breakdown, decreased removal of waste, and increased infiltration of immune cells. This leads to disruption of glial and neuronal cells, causing hormonal dysregulation, increased immune sensitivity, or cognitive impairment depending on the affected brain region. Inflammatory effects of metabolic syndrome have been linked to neurodegenerative diseases. In this review, we discuss the effects of obesity and diabetes-induced inflammation on the BBB, the roles played by leptin and insulin resistance, as well as BBB changes occurring at the molecular level. We explore signaling pathways including VEGF, HIFs, PKC, Rho/ROCK, eNOS, and miRNAs. Finally, we discuss the broader implications of neural inflammation, including its connection to Alzheimer’s disease, multiple sclerosis, and the gut microbiome.

8 July 2015 in Annual Review of Neuroscience
Verified
Journal Article
Closed access
BABenjamin J. Andreone
Benjamin J. Andreone
BLBaptiste Lacoste
Baptiste Lacoste
CGChenghua Gu
Chenghua Gu
The brain, which represents 2% of body mass but consumes 20% of body energy at rest, has a limited capacity to store energy and is therefore highly dependent on oxygen and glucose supply from the blood stream. Normal functioning of neural circuits thus relies on adequate matching between metabolic needs and blood supply. Moreover, not only does the brain need to be densely vascularized, it also requires a tightly controlled environment free of toxins and pathogens to provide the proper chemical composition for synaptic transmission and neuronal function. In this review, we focus on three major factors that ensure optimal brain perfusion and function: the patterning of vascular networks to efficiently deliver blood and nutrients, the function of the blood–brain barrier to maintain brain homeostasis, and the regulation of cerebral blood flow to adequately couple energy supply to neural function.

1 September 2014 in Neuron
Verified
Journal Article
Closed access
BLBaptiste Lacoste
Baptiste Lacoste
CCCesar H. Comin
Cesar H. Comin
ABAyal Ben-Zvi
Ayal Ben-Zvi
PKPascal S. Kaeser
Pascal S. Kaeser
XXXiaoyin Xu
Xiaoyin Xu
CGChenghua Gu
Chenghua Gu

18 February 2022 in Science
Verified
Journal Article
Closed access
MMMaud Martin
Maud Martin
SVSimon Vermeiren
Simon Vermeiren
NBNaguissa Bostaille
Naguissa Bostaille
MEMarie Eubelen
Marie Eubelen
DSDaniel Spitzer
Daniel Spitzer
BVBenoit Vanhollebeke
Benoit Vanhollebeke
The blood-brain barrier (BBB) protects the central nervous system (CNS) from harmful blood-borne factors. Although BBB dysfunction is a hallmark of several neurological disorders, therapies to restore BBB function are lacking. An attractive strategy is to repurpose developmental BBB regulators, such as Wnt7a, into BBB-protective agents. However, safe therapeutic use of Wnt ligands is complicated by their pleiotropic Frizzled signaling activities. Taking advantage of the Wnt7a/b-specific Gpr124/Reck co-receptor complex, we genetically engineered Wnt7a ligands into BBB-specific Wnt activators. In a “hit-and-run” adeno-associated virus–assisted CNS gene delivery setting, these new Gpr124/Reck-specific agonists protected BBB function, thereby mitigating glioblastoma expansion and ischemic stroke infarction. This work reveals that the signaling specificity of Wnt ligands is adjustable and defines a modality to treat CNS disorders by normalizing the BBB.